CHANGES IN SERUM COMPLEMENT ACTIVITY IN PATIENTS WITH MYASTHENIA GRAVIS

被引:0
作者
NASTUK, WL
PLESCIA, OJ
OSSERMAN, KE
机构
来源
PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE | 1960年 / 105卷 / 01期
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:177 / 184
页数:8
相关论文
共 50 条
  • [31] Effect of Complement Inhibition on Lymphocytes in Treatment Refractory Myasthenia Gravis Patients
    Guptill, Jeffrey
    Howard, James
    Russo, Melissa
    Emmett, Doug
    Chopra, Manisha
    Juel, Vern
    Massey, Janice
    Hobson-Webb, Lisa
    Yi, John
    NEUROLOGY, 2020, 94 (15)
  • [33] The in vivo role of complement activation in myasthenia gravis
    Romi, F
    Kristoffersen, EK
    Aarli, JA
    Gilhus, NE
    JOURNAL OF NEUROIMMUNOLOGY, 2004, 154 (1-2) : 150 - 150
  • [34] The role of complement in experimental autoimmune myasthenia gravis
    Kusner, Linda L.
    Kaminski, Henry J.
    MYASTHENIA GRAVIS AND RELATED DISORDERS I, 2012, 1274 : 127 - 132
  • [35] ACTIVATED COMPLEMENT IN HUMAN MYASTHENIA-GRAVIS
    BREY, R
    MCATEE, R
    BAROHN, R
    ANNALS OF NEUROLOGY, 1991, 30 (02) : 263 - 263
  • [36] Targeting complement system to treat myasthenia gravis
    Huda, Ruksana
    Tuzun, Erdem
    Christadoss, Premkumar
    REVIEWS IN THE NEUROSCIENCES, 2014, 25 (04) : 575 - 583
  • [38] Myasthenia gravis: the role of complement at the neuromuscular junction
    Howard, James F., Jr.
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2018, 1412 (01) : 113 - 128
  • [39] Complement associated pathogenic mechanisms in myasthenia gravis
    Tuzun, Erdem
    Christadoss, Premkumar
    AUTOIMMUNITY REVIEWS, 2013, 12 (09) : 904 - 911
  • [40] COMPLEMENT INHIBITION IN MYASTHENIA GRAVIS: A TRANSFORMATIVE THERAPY
    Howard, James F., Jr.
    MUSCLE & NERVE, 2019, 60 : S1 - S1